L3VLUP
ProSign in

MGNX in the 13F filings

Macrogenics Inc · CUSIP 556099109

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Quarter end
30 Jun 2022
the date the book describes
Filed
19 Aug 2022
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q1 2022 and Q2 2022; 1 listed it in both
Shares listed
578,188
combined, among listed positions
Reported value
$1.7m
combined, at the quarter end

Managers listing MGNX in Q2 2022

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2022, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
Walleye Capital LLC578,188$1.7munder 0.1%Added+364,21019 Aug 2022 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2022 to Q2 2022, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q4 2022 to 1 in Q3 2024

Tracked managers listing it, at least.

0246201520162017201820192021202220232024
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
MGNX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20143$52mn.a.n.a.
Q3 20143$39mn.a.n.a.
Q4 20143$67mn.a.n.a.
Q1 20153$87mn.a.n.a.
Q2 20153$112mn.a.n.a.
Q3 20154$76mn.a.n.a.
Q4 20155$78mn.a.n.a.
Q1 20163$49mn.a.n.a.
Q2 20163$78mn.a.n.a.
Q3 20163$66mn.a.n.a.
Q4 20162$28mn.a.n.a.
Q1 20171$22mn.a.n.a.
Q2 20171$19mn.a.n.a.
Q3 20171$22mn.a.n.a.
Q4 20171$21mn.a.n.a.
Q1 20182$28mn.a.n.a.
Q2 20181$22mn.a.n.a.
Q3 20181$24mn.a.n.a.
Q1 20192$30mn.a.n.a.
Q2 20193$58mn.a.n.a.
Q3 20193$45mn.a.n.a.
Q2 20203$72mn.a.n.a.
Q3 20202$92mn.a.n.a.
Q4 20203$38mn.a.n.a.
Q1 20212$20mn.a.n.a.
Q2 20214$60mn.a.n.a.
Q3 20212$36mn.a.n.a.
Q4 20212$25mn.a.n.a.
Q1 20223$5.5mn.a.n.a.
Q2 20221$1.7mn.a.n.a.
Q3 20222$4.5mn.a.n.a.
Q4 20223$8.7mn.a.n.a.
Q1 20232$9.7mn.a.n.a.
Q2 20233$8.8mn.a.n.a.
Q3 20232$8.1mn.a.n.a.
Q4 20232$10m12
Q1 20243$14m22
Q2 20243$5.9m30
Q3 20241$527k10

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

MGNX and LLY →MGNX and JNJ →MGNX and VRTX →Choose a stock to compare with MGNX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own MGNX, latest filings →Back to the 13F Explorer →